匹地利珠单抗
Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$800.00
Member price
Product Availability
3-5days
Price
$2300.00
Member price
Product Availability
3-5days
Price
$4200.00
Member price
Product Availability
3-5days
Price
$18500.00
Member price
Product Availability
3-5days
Price
$34000.00
Member price
Quantity
- +
Product Overview
Product Name Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
CAS1036730-42-3
Security information
Product details

Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.

Related literature
Related
Sorry, no related items
History
Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
Photochlor(HPPH); HPPH
Mifamurtide | CGP-19835| MTP-PE | L-MTP-PE
Midostaurin | PKC412 | CGP 41231 | CGP 41251
24, 25-Dihydroxy VD2; 24,25-Dihydroxy vitamin D2;24,25-Dihydroxyvitamin D2; (4E,6R)-2,3-Dimethyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-4-heptene-2,3-diol
NS-304 (Selexipag; ACT-293987)
ALM301
(S)-Tenofovir (Synonyms:(S)-GS 1278; (S)-PMPA; (S)-TDF)
Lenacapavir (Synonyms: GS-6207)
PT-2385